Brookstone Capital Management Boosts Stake in Procter & Gamble Company (The) $PG

Brookstone Capital Management grew its stake in Procter & Gamble Company (The) (NYSE:PG) by 13.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 62,894 shares of the company’s stock after buying an additional 7,313 shares during the quarter. Brookstone Capital Management’s holdings in Procter & Gamble were worth $9,013,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of PG. Halbert Hargrove Global Advisors LLC purchased a new stake in Procter & Gamble in the 3rd quarter worth $25,000. Saranac Partners Ltd purchased a new position in shares of Procter & Gamble in the third quarter valued at $30,000. Corundum Trust Company INC purchased a new stake in shares of Procter & Gamble during the 3rd quarter valued at about $32,000. Caitlin John LLC bought a new stake in shares of Procter & Gamble in the 3rd quarter valued at approximately $34,000. Finally, Marquette Asset Management LLC purchased a new position in Procter & Gamble during the third quarter worth $37,000. 65.77% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, insider Moses Victor Javier Aguilar sold 15,169 shares of the business’s stock in a transaction dated Friday, February 13th. The shares were sold at an average price of $162.28, for a total transaction of $2,461,625.32. Following the completion of the sale, the insider owned 44,735 shares of the company’s stock, valued at $7,259,595.80. The trade was a 25.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Chairman Jon R. Moeller sold 162,232 shares of the business’s stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $162.45, for a total value of $26,354,588.40. Following the sale, the chairman owned 319,385 shares of the company’s stock, valued at approximately $51,884,093.25. This trade represents a 33.68% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 348,618 shares of company stock valued at $55,462,643. 0.20% of the stock is owned by company insiders.

Procter & Gamble Trading Down 0.2%

Procter & Gamble stock opened at $144.44 on Wednesday. The stock’s 50 day simple moving average is $153.88 and its two-hundred day simple moving average is $149.88. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $174.80. The firm has a market cap of $335.67 billion, a PE ratio of 21.40, a P/E/G ratio of 4.84 and a beta of 0.37. The company has a current ratio of 0.72, a quick ratio of 0.51 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Friday, January 23rd. The company reported $1.88 earnings per share for the quarter, beating analysts’ consensus estimates of $1.86 by $0.02. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The company had revenue of $22.21 billion during the quarter, compared to analysts’ expectations of $22.36 billion. During the same quarter in the previous year, the company earned $1.88 earnings per share. The firm’s revenue for the quarter was up 1.5% on a year-over-year basis. Analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, February 17th. Investors of record on Friday, January 23rd were paid a $1.0568 dividend. The ex-dividend date of this dividend was Friday, January 23rd. This represents a $4.23 dividend on an annualized basis and a yield of 2.9%. Procter & Gamble’s dividend payout ratio (DPR) is currently 62.52%.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on PG. Piper Sandler initiated coverage on Procter & Gamble in a research note on Wednesday, January 7th. They set a “neutral” rating and a $150.00 target price on the stock. Deutsche Bank Aktiengesellschaft lowered their price target on shares of Procter & Gamble from $171.00 to $162.00 and set a “hold” rating for the company in a research report on Monday. BNP Paribas Exane dropped their price objective on Procter & Gamble from $172.00 to $164.00 and set an “outperform” rating on the stock in a research report on Friday, January 16th. Wells Fargo & Company restated an “overweight” rating and issued a $177.00 target price on shares of Procter & Gamble in a research note on Tuesday, February 17th. Finally, Dbs Bank raised Procter & Gamble from a “hold” rating to a “buy” rating in a report on Friday, January 23rd. Twelve investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $167.83.

Procter & Gamble News Summary

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: OLAY peptide research — New clinical and mechanistic data presented for OLAY highlight proprietary peptide technology and cell‑adhesion targets that P&G plans to move rapidly into formulations; successful commercialization could bolster pricing power and organic growth for a core beauty brand. OLAY Peptide Research Puts New Spotlight On Procter And Gamble Valuation
• Positive Sentiment: Analysts remain constructive in places — coverage notes that P&G can fare better than peers amid sluggish consumer sentiment, supporting the view of PG as a relatively defensive consumer staples holding. Analysts Constructive on The Procter & Gamble (PG) Amid Sluggish Consumer Sentiment
• Neutral Sentiment: Recent trading strength — PG ticked higher while the broader market fell on 3/30, showing relative strength that may reflect defensive demand; however this was a short‑term move rather than new fundamental news. Procter & Gamble (PG) Ascends While Market Falls: Some Facts to Note
• Neutral Sentiment: Q4 results mixed — Q4 EPS slightly beat estimates (+$0.02) while revenue marginally missed; steady margins and cash flow help the case for the dividend and buybacks, but top‑line softness tempers upside. (Earnings detail from recent company report.)
• Neutral Sentiment: Deutsche Bank trimmed its price target (from $171 to $162) but kept a Hold — this narrows upside but is not a sell signal; investors should weigh this against other analyst views. Deutsche Bank Lowers Price Target on PG
• Neutral Sentiment: Unrelated retailer weakness — a separate report on RH’s weak quarter is unlikely to directly affect PG but signals broader discretionary‑spending challenges in retail. RH (RH) Lags Q4 Earnings and Revenue Estimates
• Negative Sentiment: TD Cowen cut its price target to $142 (from $156) and kept a Hold, citing oil‑linked input cost inflation tied to the Iran war that it believes P&G cannot fully absorb — this is the main near‑term headwind pressuring the stock. Wall Street Downgrades Procter & Gamble Amid Iran War Cost Pressures and More

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.